Packaging

Although the discussion about the use of preservatives is still somewhat controversial, clinical evidence suggests that patients benefit from unpreserved eye drops especially in chronic conditions.

Regulators are driving serialization and tamper-evident packaging initiatives, but is the pharma industry fully primed to defend against counterfeits?

The technology has barely changed over the last 30 years – surely, it’s time for some long overdue innovation.

Using tiny imperfections in the printing process to track individual products through the supply chain

But can pharma manufacturers do more to help prevent medication errors?

Just how prevalent is pharmacogenomic information on European drug labels?

What’s convenient for manufacturers does not always result in a product that’s best for patients.

Understanding the role of ready-to-use solutions and flexibility when it comes to primary packaging for biologics